NCT06530004View on ClinicalTrials.gov

Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2028

Conditions
Nephrotic SyndromeRituximabChildrenEfficacy
Interventions
DRUG

Rituximab

B lymphocyte reconstitution was performed regularly after the administration of rituximab, and 1-4 doses of rituximab were given according to the exhaustion of B cells in children.

Trial Locations (1)

361003

RECRUITING

First affiliated hospital of xiamen university, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER